Chatzikonstantinou Anastasios, Wolf Marc E, Schaefer Anke, Hennerici Michael G
Department of Neurology, UniversitätsMedizin Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Stroke Res Treat. 2012;2012:340798. doi: 10.1155/2012/340798. Epub 2012 Jan 23.
Since many years, clinical decisions about the management of patients with carotid stenosis have been based on the distinction between "asymptomatic" and "symptomatic" presentations. This was also reflected by the design of previous studies on the surgical versus conservative treatment and of current studies on interventional treatment versus surgery. Both terms, however, only address different phases of activity of the one and the same condition and blur the significant message that carotid stenosis is a most important marker of systemic atherosclerosis, which is accompanied by a much higher risk of cardiovascular events rather than stroke. As a consequence, early diagnosis and followup during best medical treatment, life-style management, regular cardiovascular assessment, and good control of all vascular risk factors should be recommended in all patients with carotid stenosis-whether identified in the long-lasting "silent" or short-lasting "vulnerable" period lasting only a few weeks after cerebral ischemia. Patients in this short time window benefit from additional carotid intervention, under the condition of an individually favorable benefit-risk ratio ("individual vulnerability").
多年来,关于颈动脉狭窄患者治疗的临床决策一直基于“无症状”和“有症状”表现的区分。这也反映在以往关于手术治疗与保守治疗的研究设计以及当前关于介入治疗与手术治疗的研究设计中。然而,这两个术语仅涉及同一疾病的不同活动阶段,模糊了一个重要信息,即颈动脉狭窄是全身动脉粥样硬化的一个重要标志,它伴随着更高的心血管事件风险而非中风风险。因此,对于所有颈动脉狭窄患者,无论其是在长期的“无症状”期还是在脑缺血后仅持续几周的短暂“易损”期被发现,都应建议在最佳药物治疗期间进行早期诊断和随访、生活方式管理、定期心血管评估以及对所有血管危险因素进行良好控制。在个体获益风险比有利(“个体易损性”)的情况下,处于这个短时间窗口的患者可从额外的颈动脉干预中获益。